In multivariate approach limited to monotherapy patients, after correcting for age, underlying kidney disease, modality therapy duration, IDWG, serum parathyroid hormone, albumin, and blood hemoglobin, the effect of treatment choice remained significant. Here, PTH is linked to kidney disorder.